# JAK2 V617F — Final Scientific Validation Report

**Project:** JAK2-V617F-Molecular-Diagnosis  
**Author:** Daniel Hananiya  
**Validation date:** 2026-08-28  
**Purpose:** Final pre-release scientific, computational, and safety review

## 1. Scope

This report documents the final validation state of the repository as a **research/educational computational case study**. It is not a clinical assay validation report.

## 2. Canonical variant verification

The repository uses the following canonical representation:

- Gene: **JAK2**
- MANE/RefSeq transcript: **NM_004972.4**
- cDNA change: **NM_004972.4:c.1849G>T**
- Protein consequence: **p.Val617Phe (V617F)**
- dbSNP: **rs77375493**
- GRCh38 genomic representation: **NC_000009.12:g.5073770G>T**
- Reference codon: **GTC**
- Alternate codon: **TTC**

These identifiers are cross-checked against current NCBI ClinVar information and independent peer-reviewed literature.

## 3. Computational validation

The production analysis engine in `scripts/reference_sequence_analysis.py`:

1. retrieves `NM_004972.4` from NCBI at runtime;
2. parses the FASTA record;
3. checks the reference base at coding position 1849;
4. extracts the affected three-base codon;
5. introduces the G>T substitution in silico;
6. translates the reference and alternate codons; and
7. verifies the expected `p.Val617Phe` consequence.

The repository also contains deterministic unit tests so the core analysis logic can be tested independently of network availability.

## 4. Notebook validation

`analysis/JAK2_V617F_Analysis.ipynb` includes an explicit **offline deterministic validation fixture**. The fixture is synthetic test data and is deliberately labelled as such; it is not presented as a copy of the NCBI biological reference sequence.

The offline validation asserts:

```text
NM_004972.4:c.1849G>T
GTC (Val) → TTC (Phe)
p.Val617Phe
```

This separation prevents a synthetic fixture from being mistaken for authoritative biological reference data.

## 5. Automated quality control

The repository's GitHub Actions workflow has been configured to exercise the deterministic test suite across supported Python versions and to run the public-data analysis component. The latest pre-finalization CI evidence was green across the supported Python matrix and public-data runtime.

## 6. Biological interpretation safety

JAK2 V617F is a recognized driver mutation in classical BCR::ABL1-negative myeloproliferative neoplasms. The repository correctly frames molecular testing as one component of an integrated diagnostic process.

The project explicitly states that:

- a molecular result must be interpreted with clinical and hematologic findings;
- CBC and morphology remain important components of MPN evaluation;
- other molecular drivers such as CALR and MPL may be relevant; and
- a negative JAK2 V617F result does not by itself exclude an MPN.

## 7. Variant-database safety

A specific safety correction is maintained in the documentation: **aggregate germline classifications in ClinVar must not be presented as equivalent to somatic oncogenicity or clinical-impact assertions for MPNs.** The repository therefore avoids using a generic ClinVar “pathogenic” label as a stand-alone statement of somatic MPN classification.

## 8. Clinical-use boundary

The repository is explicitly labelled:

> **Educational/research workflow; not a clinical diagnostic assay.**

No patient data are required by the workflow. No patient-specific diagnosis, treatment recommendation, or clinical decision is generated.

## 9. Reproducibility

The repository contains source code, tests, notebook analysis, documentation, citation metadata, workflow configuration, provenance statements, and an academic project report. The production reference sequence is retrieved by accession rather than silently shipping an untracked third-party sequence copy.

## 10. Final release decision

### Scientific integrity: PASS

The canonical variant identity and molecular consequence are internally consistent and independently cross-checked.

### Computational reproducibility: PASS

The analysis engine, deterministic tests, notebook validation path, and CI workflow provide a reproducible computational structure.

### Clinical safety boundary: PASS

The project does not claim clinical assay validation or provide patient-management recommendations.

### Documentation: PASS

README, workflow documentation, academic report, citation metadata, limitations, and this validation report are present.

### Release readiness: CONDITIONAL PASS

The repository is scientifically safe to present as a **research/educational portfolio project**. Before assigning a formal `v1.0.0` release tag, the final post-commit GitHub Actions run should be confirmed green on the exact final commit.

## 11. Validation references

- NCBI ClinVar: `NM_004972.4(JAK2):c.1849G>T (p.Val617Phe)`; Variation ID 14662.
- NCBI RefSeq: `NM_004972.4`, Homo sapiens JAK2 transcript variant 1 mRNA.
- Peer-reviewed literature describing the canonical GTC→TTC V617F consequence and its MPN context.

**Final safety principle:** computational evidence can support molecular interpretation, but it does not substitute for validated laboratory testing, current diagnostic criteria, or qualified clinical judgment.
